Suppr超能文献

采用纳升超高效液相色谱/串联质谱法(nano-UHPLC-MS/MS)结合选择反应监测技术,靶向精准定量 12 个人源重组尿苷二磷酸葡萄糖醛酸转移酶 1A 和 2B 同工酶。

Targeted precise quantification of 12 human recombinant uridine-diphosphate glucuronosyl transferase 1A and 2B isoforms using nano-ultra-high-performance liquid chromatography/tandem mass spectrometry with selected reaction monitoring.

机构信息

Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (J.K.F., P.C.S.); and Department. of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Andover, Massachusetts, (H.N.) and Groton, Connecticut, (T.C.G.).

出版信息

Drug Metab Dispos. 2013 Dec;41(12):2076-80. doi: 10.1124/dmd.113.053801. Epub 2013 Sep 17.

Abstract

Quantification methods employing stable isotope-labeled peptide standards and liquid chromatography-tandem mass spectrometry are increasingly being used to measure enzyme amounts in biologic samples. Isoform concentrations, combined with catalytic information, can be used in absorption, distribution, metabolism, and excretion studies to improve accuracy of in vitro/in vivo predictions. We quantified isoforms of uridine-diphosphate glucuronosyltransferase (UGT) 1A and 2B in 12 commercially available recombinant UGTs (recUGTs) (n = 49 samples) using nano-ultra-high-performance liquid chromatography-tandem mass spectrometry with selected reaction monitoring). Samples were trypsin-digested and analyzed using our previously published method. Two MRMs were collected per peptide and averaged. Where available, at least two peptides were measured per UGT isoform. The assay could detect UGTs in all recombinant preparations: recUGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B15, and 2B17, with limit of detection below 1.0 pmol/mg protein for all isoforms. The assay had excellent linearity in the range observed (2-15.5 pmol/mg, after dilution). Examples of concentrations determined were 1465, 537, 538, 944, 865, 698, 604, 791, 382, 1149, 307, and 740 pmol/mg protein for the respective isoforms. There was a 6.9-fold difference between the maximum and minimum recUGT concentrations. The range of concentrations determined indicates that catalytic rates per mg total protein in vitro will not accurately reflect isoform inherent specific activity for a particular drug candidate. This is the first report of a targeted precise quantification of commercially available recUGTs. The assay has potential for use in comparing UGT amounts with catalytic activity determined using probe substrates, thus allowing representation of catalysis as per pmol of UGT isoform.

摘要

采用稳定同位素标记肽标准品和液相色谱-串联质谱的定量方法越来越多地用于测量生物样品中的酶含量。同工型浓度,结合催化信息,可用于吸收、分布、代谢和排泄研究,以提高体外/体内预测的准确性。我们使用带有选择反应监测的纳超高效液相色谱-串联质谱法,对 12 种市售重组 UGT(recUGT)(n=49 个样本)中的尿苷二磷酸葡萄糖醛酸基转移酶(UGT)1A 和 2B 同工型进行了定量。样品用胰蛋白酶消化,并使用我们之前发表的方法进行分析。每个肽段采集两个 MRM 并取平均值。对于每个 UGT 同工型,至少测量两个肽段。该测定法可检测所有重组制剂中的 UGT:recUGT1A1、1A3、1A4、1A6、1A7、1A8、1A9、1A10、2B4、2B7、2B15 和 2B17,所有同工型的检测限均低于 1.0 pmol/mg 蛋白。该测定法在观察到的范围内(2-15.5 pmol/mg,稀释后)具有极好的线性。所确定的浓度示例分别为相应同工型的 1465、537、538、944、865、698、604、791、382、1149、307 和 740 pmol/mg 蛋白。最大和最小 recUGT 浓度之间存在 6.9 倍的差异。所确定的浓度范围表明,体外每毫克总蛋白的催化速率不会准确反映特定候选药物的同工型固有比活性。这是首次报道市售 recUGT 的靶向精确定量。该测定法具有与使用探针底物确定的催化活性进行比较的潜力,从而可以根据 UGT 同工型的 pmol 表示催化作用。

相似文献

引用本文的文献

6
The Human UGT2B7 Nanodisc.人源 UGT2B7 纳米盘。
Drug Metab Dispos. 2020 Mar;48(3):198-204. doi: 10.1124/dmd.119.089946. Epub 2019 Dec 31.

本文引用的文献

3
Proteomics meets the scientific method.蛋白质组学符合科学方法。
Nat Methods. 2013 Jan;10(1):24-7. doi: 10.1038/nmeth.2291.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验